XML 15 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 133,681 $ 113,473
Accounts receivable, net 124,507 83,447
Inventories, net 208,305 172,099
Income taxes receivable 5,508 4,957
Other current assets 40,248 30,279
Total current assets 512,249 404,255
Property, plant and equipment, net 491,847 494,401
Deferred income tax assets, net 25,843 27,715
Intangibles, net 69,533 76,870
Other non-current assets 55,446 50,906
Total assets 1,154,918 1,054,147
Current liabilities:    
Accounts payable 229,557 153,197
Short-term debt 5,971 6,081
Accrued expenses 76,974 71,525
Income taxes payable 1,170 1,076
Total current liabilities 313,672 231,879
Long-term debt (less current portion) 597,856 602,355
Non-current income tax liabilities 7,799 8,289
Deferred income tax liabilities, net 4,327 3,913
Other non-current liabilities 74,066 77,089
Commitments and contingent liabilities (Note 16)
Mezzanine equity:    
Preferred stock, $0.01 par value Authorized - 1,000,000 shares Issued and outstanding – 150,000 shares outstanding at March 31, 2022 and December 31, 2021 205,381 199,897
European non-controlling redeemable equity 1,140 1,146
Shareholders’ deficit:    
Common stock, $0.01 par value Authorized - 100,000,000 shares Issued and outstanding – 26,853,292 and 26,163,077 shares at March 31, 2022 and December 31, 2021 104,216 103,214
Accumulated other comprehensive loss (107,027) (125,974)
Retained earnings (46,512) (47,661)
Total shareholders’ deficit (49,323) (70,421)
Total liabilities, mezzanine equity and shareholders’ deficit $ 1,154,918 $ 1,054,147